BACKGROUND AND INTRODUCTION: @entity1469 ( @entity1469 ) is a disease of the proliferative trophoblastic allograft. Diagnosis and treatment of GTN in low resource-income countries is challenging due to numerous factors. The objective of this study was to review outcomes of @entity1469 in @entity1 of low socioeconomic status with limited resources and social support. METHODS: This study was performed at Gynecologic and Obstetric Clinic of Dakar Teaching Hospital, the reference Centre of Gestational trophoblastic diseases in Senegal from 2006 to 2015. RESULTS: Out of 1088 @entity1 followed for @entity1469 during the study period, 108 @entity1 were diagnosed and treated for GTN: 88 low-risk and 20 high-risk. Low-risk @entity1 received an average of 6.9 cycles of initial single-agent chemotherapy. Twelve @entity1 had persistent disease and were switched to a second line multi-agent chemotherapy. Finally 94.3% of low-risk @entity1 achieved remission. All high-risk @entity1 were initially treated with multi-agent chemotherapy, averaging 7 cycles. Five of the eighty-eight low-risk @entity1 and twelve of the 20 high-risk @entity1 died of disease. CONCLUSION AND GLOBAL HEALTH IMPLICATIONS: Early adequate treatment ensures an excellent prognosis for @entity1 with GTN. In low-income countries, difficulties encountered in diagnosis and treatments worsen the prognosis of GTN @entity1 . Clinical trials are needed to find out affordable schedules or drugs for a better treatment.

Diagnosis, Treatment and Outcome of XXXX in a Low Resource Income Country.

@entity1 :: ('9606', 'Species') :: ['women', 'patients'] @entity1469 :: ('MESH:D031901', 'Disease') :: ['gestational trophoblastic disease', 'Gestational trophoblastic disease', 'gestational trophoblastic neoplasia', 'GTD']
@entity1469 :: (MESH:D031901,Disease) :: ['Gestational Trophoblastic Neoplasia']
